Kawasaki Motorcycles Recall Issued Due to Faulty Ignition Switch
About 4,000 Kawasaki off-road motorcycles have been recalled due to a faulty ignition switch, which federal regulators say could cause the vehicle to starts suddenly and lead to a serious injury or death for riders.
The U.S. Consumer Product Safety Commission (CPSC) announced the Kawasaki KLX110 off-road motorcycle recall on Thursday after problems with the housing on the ignition switch were discovered. The housing could allow water to enter the ignition switch and unexpectedly activate the bike’s electric starter.
Although there have been no reported injuries associated with the Kawasaki motorcycles, the CPSC warned that the defect “poses a serious hazard of injury or death.”
Did You Know?
Millions of Philips CPAP Machines Recalled
Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.Learn More
The recall affects about 4,000 of the 2010 model year Kawasaki KLX110CAF and KLX110DAF off-road motorcycles. The models were sold in green and have Kawasaki printed on the fuel tank. The recalled motorcycles were sold at Kawasaki dealers nationwide from August 2009 through February 20 for about $2,100 each. The bikes were manufactured in Thailand.
The CPSC recommends that any consumers who own a recalled Kawasaki KLX110 off-road motorcycle stop using it immediately and contact a local Kawasaki Motorcycle dealer to make an appointment for a free repair. The company has attempted to alert all known KLX110 owners affected by the recall. Kawasaki owners with questions can visit the company’s website at www.kawasaki.com.
"*" indicates required fields
More Top Stories
A new report indicates the U.S. Navy is struggling to process tens of thousands of Camp Lejeune water poisoning claims due to a lack of resources.
A group of plaintiffs have filed a motion with the U.S. JPML seeking consolidation of all Bard implanted port lawsuits before one judge for pretrial proceedings.
A Tepezza hearing loss lawsuit accuses the manufacturer of failing to provide adequate warning about the risks of the thyroid eye disease drug.